L-428 Cells

The L428 cell line is a well-established neoplastic cell line derived from the pleural effusion of a female patient diagnosed with Hodgkin's disease of the nodular sclerosing type. The establishment of this cell line has provided a valuable model for studying the cellular characteristics and molecular mechanisms underlying Hodgkin's lymphoma. L428 cells closely resemble the Reed-Sternberg (RS) and Hodgkin (H) cells, which are hallmark cells of Hodgkin's lymphoma. These cells demonstrate a unique phenotype distinct from typical B cells, T cells, and other hematopoietic cell types, contributing to ongoing debates about the exact cellular origin of RS and H cells. The L428 cell line exhibits several distinctive characteristics, including aneuploidy and the presence of multiple structural and numerical chromosomal abnormalities, which are typical markers of its neoplastic nature. These cells lack surface or cytoplasmic immunoglobulins (Igs), despite their derivation from a lymphoid malignancy, which suggests significant differentiation from normal lymphoid cells. The absence of Epstein-Barr Virus (EBV) antigens, such as EBNA and VCA, further distinguishes L428 from other EBV-positive Hodgkin's lymphoma cell lines. The cells also lack lysozyme, peroxidase, and chloracetate esterase activity, reinforcing their distinction from myeloid cells, monocytes, or macrophages. In terms of morphology, L428 cells exhibit a range of sizes, from small mononuclear cells to large multinucleated cells, with some cells displaying villous projections on their membranes. The cells are also notable for their large, often kidney-shaped nucleoli. Functionally, L428 cells express Ia-like antigens and T-cell receptors but are devoid of other common lymphoid and myeloid markers. This unique immunophenotype, combined with the chromosomal and morphological features, supports the classification of L428 as a model of Hodgkin's lymphoma, particularly for studying the biology of RS and H cells. The L428 cell line has been used extensively in research to explore the pathogenesis of Hodgkin's disease and to investigate potential therapeutic targets. Its ability to proliferate in vitro and its unique properties make it a critical resource for advancing the understanding of this complex hematological malignancy.